Lima Ana P S, Marshall Desiree A, Morrell Eric, Pipavath Sudhakar N J
Department of Radiology.
Department of Pathology.
J Thorac Imaging. 2025 Jun 23. doi: 10.1097/RTI.0000000000000837.
Acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by widespread inflammation in the lungs. It is associated with high mortality and morbidity in critically ill patients. ARDS are conditions that cause acute respiratory failure due to noncardiogenic pulmonary edema, leading to severe hypoxemia and diffuse, bilateral lung injury. These conditions represent a spectrum of lung injury with varying severity and complexity. ARDS is a more severe form of ALI. ALI can also describe a range of clinical and paraclinical findings that include one or both pathologic patterns of organizing pneumonia (OP) or diffuse alveolar damage (DAD). The pathologic correlate of ARDS is DAD. This damage can be triggered by various risk factors, including pneumonia, sepsis, trauma, and the inhalation of harmful substances. The alveolar capillary damage that accompanies DAD leads to a loss in barrier function and is associated with the accumulation of fluid into the alveolar space. This fluid accumulation (pulmonary edema), along with subsequent organization and scarring, impairs gas exchange, which leads to hypoxemia and respiratory failure. Despite advances in understanding the pathophysiology of ARDS and improvements in supportive care, the mortality rates from ARDS still range from 25% to 45%. It is crucial to recognize that radiographic and histologic findings in a patient with ARDS can vary significantly depending on the phase of the disease. This is because the pathophysiological processes underlying these conditions evolve over time, leading to changes in both clinical presentation and imaging findings. Misinterpretation of these findings could lead to incorrect diagnoses and inappropriate treatment strategies. Therefore, understanding the temporal evolution of this condition is essential for accurate diagnosis and effective management. Our paper seeks to examine the existing literature focusing on radiology and pathology at different phases of injury and resolution to enhance management of ARDS.
急性呼吸窘迫综合征(ARDS)是一种危及生命的疾病,其特征是肺部广泛炎症。它与危重症患者的高死亡率和高发病率相关。ARDS是由于非心源性肺水肿导致急性呼吸衰竭的疾病,可导致严重低氧血症和弥漫性双侧肺损伤。这些疾病代表了一系列严重程度和复杂性各异的肺损伤。ARDS是急性肺损伤(ALI)的一种更严重形式。ALI也可描述一系列临床和亚临床发现,包括机化性肺炎(OP)或弥漫性肺泡损伤(DAD)这两种病理模式中的一种或两种。ARDS的病理对应物是DAD。这种损伤可由多种危险因素触发,包括肺炎、脓毒症、创伤和吸入有害物质。伴随DAD出现的肺泡毛细血管损伤导致屏障功能丧失,并与液体在肺泡腔内积聚有关。这种液体积聚(肺水肿)以及随后的机化和瘢痕形成会损害气体交换,从而导致低氧血症和呼吸衰竭。尽管在理解ARDS的病理生理学方面取得了进展,以及支持性治疗有所改善,但ARDS的死亡率仍在25%至45%之间。必须认识到,ARDS患者的影像学和组织学表现会因疾病阶段的不同而有显著差异。这是因为这些疾病背后的病理生理过程会随时间演变,导致临床表现和影像学表现都发生变化。对这些表现的错误解读可能导致误诊和不恰当的治疗策略。因此,了解这种疾病的时间演变对于准确诊断和有效管理至关重要。我们的论文旨在研究现有文献,重点关注损伤和恢复不同阶段的放射学和病理学,以加强对ARDS的管理。